USPTO Examiner CARPENTER WILLIAM R - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19194415PORT PROTECTORApril 2025July 2025Allow200YesNo
19052872Medicament Delivery DeviceFebruary 2025June 2025Allow410NoNo
19025292Auto-InjectorJanuary 2025April 2025Allow300YesNo
19024657Auto-InjectorJanuary 2025July 2025Allow610YesNo
19025123Auto-InjectorJanuary 2025July 2025Allow610YesNo
19024865Auto-InjectorJanuary 2025March 2025Allow200YesNo
18968713SYSTEMS, METHODS, AND DEVICES FOR ADVANCING AN ENDOVASCULAR INSTRUMENTDecember 2024April 2025Allow410YesNo
18853697SLEEVE FOR RETENTION OF A SURGICAL PORT COMPRISING FLANGES THAT ARE REVERSIBLY RADIALLY EXPANDABLEOctober 2024February 2026Allow1621YesNo
18824125NASAL IRRIGATION DEVICE AND SYSTEM WITH FAUX COLLAPSIBLE CARTRIDGE ELEMENTSeptember 2024October 2024Allow200YesNo
18622233Auto-InjectorMarch 2024October 2024Allow610YesNo
18622306Auto-InjectorMarch 2024October 2024Allow610YesNo
18622358Auto-InjectorMarch 2024October 2024Allow610YesNo
18599867Auto-InjectorMarch 2024August 2024Allow510YesNo
18417604Actuator Assembly for Drug Delivery SystemJanuary 2024March 2026Allow2500YesNo
18412401VASCULATURE NAVIGATION SYSTEMS AND METHODSJanuary 2024September 2024Allow811YesNo
18401994DIALYSIS APPARATUS INCLUDING THERAPY PRESCRIPTION SELECTIONJanuary 2024October 2025Allow2211YesNo
18570293A DRUG INJECTION DEVICE AND RECYCLING SYSTEMDecember 2023July 2024Allow700YesNo
18499401System, Method, and Apparatus for Detecting Tube Misplacement in a Patient's AirwayNovember 2023August 2025Allow2100YesNo
18498416Auto-InjectorOctober 2023April 2025Allow1700YesNo
18383802Intraosseous Access DeviceOctober 2023August 2025Allow2211YesNo
18492692VALVE, IN PARTICULAR FOR A DEVICE FOR ADMINISTERING A LIQUID MEDICAMENT, AND A CORRESPONDING DEVICE FOR ADMINISTERING A LIQUID MEDICAMENTOctober 2023March 2026Allow2930YesNo
18279105BALLOON FOR BALLOON CATHETERAugust 2023February 2026Allow3000YesNo
18446585SYSTEM AND METHOD FOR ADMINISTERING AN INFUSIBLE FLUIDAugust 2023October 2025Allow2721YesNo
18225864SYSTEM FOR ANCHORING MEDICAL DEVICESJuly 2023January 2025Allow1700YesNo
18224828MEDICAL PUMPJuly 2023November 2024Allow1601YesNo
18224877BI-DIRECTIONAL ACCESS TO TUMORSJuly 2023October 2025Allow2720YesNo
18220551Needle Protection AssemblyJuly 2023October 2025Allow2720YesNo
18348443Smart Self-Activating Wearable Device for Automatically Injecting MedicinesJuly 2023May 2025Abandon2310NoNo
18333060Communication Accessory for a Drug Delivery DeviceJune 2023October 2025Allow2820YesNo
18324069IRRIGATION AND ASPIRATION DEVICE AND METHODMay 2023September 2023Allow400YesNo
18311072CATHETERS AND RELATED DEVICES AND METHODS OF MANUFACTUREMay 2023September 2024Allow1700YesNo
18142073IV TUBING CARRIAGE SYSTEMMay 2023December 2025Abandon3240YesNo
18305747AUTOMATED COMPRESSION NURSING AND PUMPING SYSTEMApril 2023February 2025Abandon2210NoNo
18302646DEVICES FOR TRANSVASCULAR RETROGRADE ACCESS PLACEMENTApril 2023October 2025Allow3020YesNo
18134841Needle Actuator Assembly for Drug Delivery SystemApril 2023March 2025Allow2311YesNo
18296292MANAGING FLUID LEVELS IN A PATIENT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSApril 2023December 2023Allow820YesNo
18125810Intravesical Drug Delivery DevicesMarch 2023January 2025Allow2211YesNo
18125849INTRAVENOUS CATHETER ASSEMBLYMarch 2023January 2026Allow3421YesNo
18110223Detachable Needle Syringe Having Reduced Dead SpaceFebruary 2023March 2025Abandon2520NoNo
18096603ADJUSTABLE SEALJanuary 2023November 2025Allow3400YesNo
18084713VASCULAR ACCESS DILATOR APPARATUS AND METHOD OF USEDecember 2022October 2025Abandon3420NoNo
18063918SYRINGEDecember 2022April 2024Allow1600YesNo
17994961Auto-InjectorNovember 2022February 2023Allow200YesNo
17989325Splittable Needle for Catheter Placement SystemNovember 2022January 2026Allow3801YesNo
17983243INTRODUCER SHEATHSNovember 2022December 2024Abandon2510NoNo
17952801Auto-InjectorSeptember 2022January 2023Allow410YesNo
17943513ULTRASOUND CATHETER AND ULTRASOUND CATHETER SYSTEMSeptember 2022February 2026Allow4210NoNo
17941793BI-DIRECTIONAL PERFUSION CANNULASeptember 2022August 2024Allow2310YesNo
17822933NEUROVASCULAR ACCESS CATHETER WITH MICROCATHETER SEGMENTAugust 2022January 2026Abandon4001NoNo
17892042Smart Self-Activating Wearable Device For Automatically Injecting MedicinesAugust 2022April 2023Allow800YesNo
17889560MEDICAMENT INJECTOR AND INTERCHANGEABLE CARTRIDGES THEREFORAugust 2022September 2025Allow3701YesNo
17795645DRUG INJECTION CONTROL DEVICE HAVING STABLE OPERATION STRUCTURE OF INJECTION BUTTON THROUGH BUTTON PLATE POSITIONED IN DOSE DIALJuly 2022November 2025Allow4010YesNo
17864796MEDICAL TUBE AND CATHETERJuly 2022January 2026Abandon4210NoNo
17860601NASAL IRRIGATION DEVICE AND SYSTEM WITH FAUX COLLAPSIBLE CARTRIDGE ELEMENTJuly 2022June 2024Allow2300YesNo
17854867Hemostasis Valve, Catheter Sheath, and Method for Sealing Interventional InstrumentJune 2022September 2025Allow3901YesNo
17854824READING DEVICE, DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE IN COMBINATION WITH A READING DEVICEJune 2022February 2026Allow4431YesNo
17850236SAFETY PEN NEEDLE ASSEMBLYJune 2022February 2024Abandon2001NoNo
17845521Auto-InjectorJune 2022August 2022Allow200YesNo
17841070PLATE WITH INTEGRAL FLUID PATH CHANNELSJune 2022April 2024Allow2201YesNo
17806681MANAGING FLUID LEVELS IN A PATIENT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSJune 2022December 2022Allow610YesNo
17783909SYRINGE WITH SAFETY MECHANISMJune 2022September 2025Allow4010NoNo
17776301SYSTEM, METHOD, AND COMPUTER PROGRAM FOR OCCLUSION DETECTION AND IMPROVED PRESSURE LIMITING BEHAVIOR FOR FLUID INJECTOR DEVICESMay 2022September 2025Allow4001YesNo
17730313WINGED NEEDLE SET SECUREMENTApril 2022December 2023Allow2010YesNo
17708975DOUBLE BALLOON VASCULAR OCCLUSION CATHETERMarch 2022May 2024Abandon2611NoNo
17706389Auto-InjectorMarch 2022May 2022Allow200YesNo
17706444Auto-InjectorMarch 2022August 2022Allow510YesNo
17761245MASKMarch 2022November 2025Allow4410NoNo
17675509SYRINGE AND METHOD OF PREPARING SYRINGEFebruary 2022May 2023Allow1500NoNo
17584627CATHETERS AND RELATED DEVICES AND METHODS OF MANUFACTUREJanuary 2022January 2023Allow1121YesNo
17574279SYSTEM AND METHOD FOR MULTIPLE SITE INJECTIONJanuary 2022February 2025Allow3700YesNo
17569143Needle Hub for Drug Delivery DeviceJanuary 2022July 2024Allow3121YesNo
17553255BALLOON CATHETER WITH ENHANCED LOCATABILITYDecember 2021May 2025Abandon4141YesNo
17552376Diabetes Overlay Patch ShieldDecember 2021February 2025Abandon3820NoNo
17618686PEN NEEDLEDecember 2021May 2025Allow4111YesNo
17525774Mechanical DilatorNovember 2021July 2025Allow4430YesNo
17524610LACRIMAL DRUG DELIVERY DEVICENovember 2021February 2024Allow2711YesNo
17518062Medicament Delivery SystemNovember 2021July 2024Allow3321YesNo
17515470HYPODERMIC NEEDLE FOR INTRA-ARTERIAL/INTRAVENOUS LINE PLACEMENTOctober 2021June 2024Abandon3120NoNo
17514429Stabilized Pen InjectorOctober 2021May 2024Allow3100NoNo
17508459SYSTEMS, METHODS AND APPARATUS FOR GUIDING AND SUPPORTING CATHETERS AND METHODS OF MANUFACTUREOctober 2021May 2022Allow720YesNo
17506437SYRINGEOctober 2021May 2023Allow1800NoNo
17450849Data Collection Apparatus for Attachment to an Injection DeviceOctober 2021August 2023Allow2210YesNo
17500174SYRINGEOctober 2021December 2022Abandon1420YesNo
17488575PUMP INFUSION SYSTEMSeptember 2021November 2024Abandon3811NoNo
17487135METHOD FOR PROCESSING INFUSION DATA AND AN INFUSION PUMP SYSTEMSeptember 2021April 2024Allow3101YesNo
17448257BALLOON CATHETER AND BALLOON ARRANGEMENT METHODSeptember 2021August 2025Allow4721NoNo
17478905WEARABLE FLUID DELIVERY SYSTEMSeptember 2021February 2026Abandon5360YesNo
17466083SYRINGE WITH SYRINGE CLOSURESeptember 2021February 2025Allow4130YesNo
17431954INJECTION NEEDLEAugust 2021April 2025Allow4430NoNo
17401996VASCULATURE NAVIGATION SYSTEMS AND METHODSAugust 2021March 2023Allow1921NoNo
17398141VOLUME-BASED FLOW RATE COMPENSATION TECHNIQUE FOR INFUSION THERAPYAugust 2021December 2023Allow2800NoNo
17381737Syringe CarrierJuly 2021October 2022Allow1510YesNo
17380749INJECTOR AND METHOD OF ASSEMBLYJuly 2021July 2025Allow4841YesNo
17368936DEVICE FOR THE DOSED ADMINISTRATION OF A FLUID PRODUCT, ADAPTED FOR THE REPLACEMENT OF A CONTAINERJuly 2021November 2023Allow2800YesNo
17419187DEVICE AND METHOD FOR DELIVERING AN INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USERJune 2021May 2024Allow3501YesNo
17363475METHOD OF USING AN INDWELLING CATHETER APPARATUS INCLUDING DISPOSABLE ANTI-MICROBIAL SLEEVEJune 2021March 2022Abandon910NoNo
17361912APPARATUSES AND METHODS FOR INJECTING MEDICAMENTSJune 2021March 2025Allow4521YesNo
17354559HEMOSTATIC VALVE, SHEATH, AND CATHETER SHEATH ASSEMBLYJune 2021November 2024Abandon4110NoNo
17416023CATHETER SYSTEMS AND RELATED METHODSJune 2021September 2024Abandon3910NoNo
17335684SYRINGEJune 2021October 2021Allow510YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CARPENTER, WILLIAM R.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
28
Examiner Affirmed
17
(60.7%)
Examiner Reversed
11
(39.3%)
Reversal Percentile
60.8%
Higher than average

What This Means

With a 39.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
52
Allowed After Appeal Filing
14
(26.9%)
Not Allowed After Appeal Filing
38
(73.1%)
Filing Benefit Percentile
39.3%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 26.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner CARPENTER, WILLIAM R - Prosecution Strategy Guide

Executive Summary

Examiner CARPENTER, WILLIAM R works in Art Unit 3783 and has examined 446 patent applications in our dataset. With an allowance rate of 64.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner CARPENTER, WILLIAM R's allowance rate of 64.3% places them in the 25% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by CARPENTER, WILLIAM R receive 2.72 office actions before reaching final disposition. This places the examiner in the 80% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by CARPENTER, WILLIAM R is 37 months. This places the examiner in the 34% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +53.7% benefit to allowance rate for applications examined by CARPENTER, WILLIAM R. This interview benefit is in the 95% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 20.7% of applications are subsequently allowed. This success rate is in the 23% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 16.3% of cases where such amendments are filed. This entry rate is in the 18% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 36.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 35% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 21% percentile among all examiners. Of these withdrawals, 42.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 65.2% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.4% of allowed cases (in the 64% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.